Bernard Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02K Hold
11
﹤0.01% 291
2025
Q4
$1.94K Hold
11
﹤0.01% 286
2025
Q3
$1.54K Hold
11
﹤0.01% 280
2025
Q2
$1.38K Hold
11
﹤0.01% 274
2025
Q1
$1.51K Hold
11
﹤0.01% 325
2024
Q4
$1.68K Buy
+11
New +$1.85K ﹤0.01% 272

Other funds holding BIIB

Bernard Wealth Management's BIIB Position: Q1 2026 in Review

Bernard Wealth Management held its Biogen (BIIB) position steady in Q1 2026 at 11 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #291.

Bernard Wealth Management first reported a position in BIIB in Q4 2024 and has held it in 6 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Bernard Wealth Management held 11 shares of Biogen worth $2.02K as of Q1 2026.
  • Bernard Wealth Management left its Biogen share count unchanged in Q1 2026.
  • Biogen made up ﹤0.01% of Bernard Wealth Management's portfolio in Q1 2026, its #291 holding.
  • Bernard Wealth Management first reported a position in Biogen in Q4 2024 and has held it in 6 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Bernard Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.